RHO and coronary artery disorder: Several papers have reported the different effect of rosuvastatin and atorvastatin on atherosclerotic changes; ie, the greater decrease in coronary atheroma volume was observed in the rosuvastatin than atorvastatin group in CAD patients [31] and the different effects of Rho/Rho (ROCK) kinase pathway on the blood leukocytes [32].